YH-13Homo sapiens (Human)Cancer cell line

Also known as: YH, YH13

🤖 AI SummaryBased on 7 publications

Quick Overview

Human glioblastoma cell line with known MGMT activity and chemosensitivity profiles.

Detailed Summary

The YH-13 cell line is a human glioblastoma-derived cell line established from a 49-year-old male patient with a frontoparietal glioblastoma. It exhibits a fibroblastic growth pattern in culture and expresses glial fibrillary acidic protein (GFAP) and S-100 protein, indicating an astrocytic origin. YH-13 demonstrates high O6-methylguanine-DNA methyltransferase (MGMT) activity, which correlates with resistance to chloroethylnitrosourea (ACNU) chemotherapy. This cell line has been used to study the relationship between MGMT expression and chemosensitivity in glioblastoma, providing insights into the mechanisms of drug resistance. YH-13 has been passaged over 50 times and maintains consistent morphological and immunohistochemical characteristics, making it a valuable model for investigating glioblastoma biology and therapeutic responses.

Research Applications

Chemosensitivity testingMGMT activity analysisDrug resistance mechanismsTumor biology studies

Key Characteristics

High MGMT activityFibroblastic growth patternGFAP and S-100 expressionResistance to ACNU
Generated on 6/17/2025

Basic Information

Database IDCVCL_1795
SpeciesHomo sapiens (Human)
Tissue SourceBrain, left fronto-parietal lobe

Donor Information

Age40
Age CategoryAdult
SexMale

Disease Information

DiseaseGlioblastoma
LineageCNS/Brain
SubtypeGlioblastoma
OncoTree CodeGB

DepMap Information

Source TypeHSRRB
Source IDACH-000469_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Phe113Val (c.337T>G)Homozygous-Unknown, Unknown
MutationSimplePIK3CAp.Gln75Glu (c.223C>G)Heterozygous-Unknown, Unknown

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
10
D13S317
9,12
D16S539
12
D5S818
10,12
D7S820
8,12
TH01
8
TPOX
8
vWA
18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens.

Stronach E.A., Saez-Rodriguez J., Yusa K., Garnett M.J.

Nature 568:511-516(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Signatures of mutation and selection in the cancer genome.";

Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.

Nature 463:893-898(2010).

Overexpressed Skp2 within 5p amplification detected by array-based comparative genomic hybridization is associated with poor prognosis of glioblastomas.

Aoyagi M., Ohno K., Imoto I., Inazawa J.

Cancer Sci. 96:676-683(2005).

Characterization and chemosensitivity of two cell lines derived from human glioblastomas.

Izumu I., Mineura K., Watanabe K., Kowada M.

J. Neurooncol. 17:111-121(1993).

Establishment of the two glioma cell lines: YH and AM.";

Izumi I., Mineura K., Watanabe K., Kowada M.

Hum. Cell 7:101-105(1994).

Brain tumors.";

Ali-Osman F.

(In book chapter) Human cell culture. Vol. 2. Cancer cell lines part 2; Masters J.R.W., Palsson B.O. (eds.); pp.167-184; Kluwer Academic Publishers; New York; USA (1999).